Sign Up to like & get
recommendations!
0
Published in 2024 at "Cardiovascular Research"
DOI: 10.1093/cvr/cvae088.106
Abstract: Funding Acknowledgements  Type of funding sources: Foundation. Main funding source(s): Leducq Foundation Phospholamban (PLN) is a key modulator of sarcoplasmic reticulum Ca2+ homeostasis and cardiac contractility. The PLN variant c.40_42delAGA (p.R14del) leads to arrhythmogenic cardiomyopathy…
read more here.
Keywords:
disease;
culture;
protein;
r14del ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23136947
Abstract: Phospholamban (PLN), a key modulator of Ca2+-homeostasis, inhibits sarcoplasmic reticulum (SR) calcium-ATPase (SERCA2a) and regulates cardiac contractility. The human PLN mutation R14del has been identified in arrhythmogenic cardiomyopathy patients worldwide and is currently extensively investigated.…
read more here.
Keywords:
inhibition;
serca2a;
r14del;
pln r14del ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24032675
Abstract: Phospholamban (PLN) is a major regulator of cardiac contractility, and human mutations in this gene give rise to inherited cardiomyopathies. The deletion of Arginine 14 is the most-prevalent cardiomyopathy-related mutation, and it has been linked…
read more here.
Keywords:
r14del pln;
phospholamban;
r14del;
myofilament alterations ... See more keywords